Chronic renoprotective effect of pulsatile perfusion machine RM3 and IGL-1 solution in a preclinical kidney transplantation model

Journal of Translational Medicine

Volumn 10, Issue 1, 2012, Pages

  Thuillier, Raphael ^a,b,c,d   Codas, Ricardo ^c,d   Marchand, Etienne ^b   Lathelize, Hubert ^b   Page, Olivier ^b   Valagier, Alexandre ^e   Badet, Lionel ^a,c,e,f   Hauet, Thierry ^a,b,c,g,h  

^a UNIVERSITÉ DE POITIERS   (France)

^b POITIERS UNIVERSITY HOSPITAL   (France)

^c Fédération pour L'étude de l'Ischémie Reperfusion en Transplantation   (France)

^d Service d'Urologie et chirurgie de la transplantation   (France)

^e UNIVERSITÉ LYON 1   (France)

^f Oullins Cedex ^*  (France)

^g Domaine du Magneraud   (France)

^h INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; CREATININE; INSTITUTE GEORGE LOPEZ 1 SOLUTION; INTERLEUKIN 10; MACHINE PERFUSION SOLUTION SOLUTION; PRESERVATION SOLUTION; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOTRANSPLANTATION; CHRONIC INFLAMMATION; COLD ISCHEMIA; CONTROLLED STUDY; CRYOPRESERVATION; EPITHELIAL MESENCHYMAL TRANSITION; FOLLOW UP; ISCHEMIA; KIDNEY FIBROSIS; KIDNEY GRAFT; KIDNEY PERFUSION; KIDNEY TRANSPLANTATION; MACHINE PERFUSION; NONHUMAN; PROTEINURIA; PULSATILE PERFUSION MACHINE; RENAL PROTECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; UROLOGICAL EQUIPMENT;

ANIMALS; BIOLOGICAL MARKERS; CHRONIC DISEASE; CRYOPRESERVATION; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROSIS; INFLAMMATION; KIDNEY; KIDNEY TRANSPLANTATION; MODELS, ANIMAL; MULTIVARIATE ANALYSIS; ORGAN PRESERVATION SOLUTIONS; PHENOTYPE; PROTECTIVE AGENTS; PULSATILE FLOW; RECOVERY OF FUNCTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS; SWINE;

EID: 84869216028     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-10-233     Document Type: Article

References (32)

1. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, Held PJ, Port FK. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999, 341:1725-1730. 10.1056/NEJM199912023412303, 10580071.
2. UNOS Annual report of the US scientific registry of transplants recipients and the organ procurement and transplantation 2004, http://www.unos.org, UNOS.
3. Johnston TD, Thacker LR, Jeon H, Lucas BA, Ranjan D. Sensitivity of expanded-criteria donor kidneys to cold ischaemia time. Clin Transplant 2004, 18(Suppl 12):28-32.
4. Cecka JM. Donors without a heartbeat. N Engl J Med 2002, 347:281-283. 10.1056/NEJMe020069, 12140306.
5. Wight J, Chilcott J, Holmes M, Brewer N. The clinical and cost-effectiveness of pulsatile machine perfusion versus cold storage of kidneys for transplantation retrieved from heart-beating and non-heart-beating donors. Health Technol Assess 2003, 7:1-94.
6. Moers C, Smits JM, Maathuis MH, Treckmann J, van Gelder F, Napieralski BP, van Kasterop-Kutz M, van der Heide JJ, Squifflet JP, van Heurn E, et al. Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med 2009, 360:7-19. 10.1056/NEJMoa0802289, 19118301.
7. Treckmann J, Moers C, Smits JM, Gallinat A, Maathuis MH, van Kasterop-Kutz M, Jochmans I, Homan van der Heide JJ, Squifflet JP, van Heurn E, et al. Machine perfusion versus cold storage for preservation of kidneys from expanded criteria donors after brain death. Transpl Int 2011, 24:548-554. 10.1111/j.1432-2277.2011.01232.x, 21332580.
8. Jochmans I, Moers C, Smits JM, Leuvenink HG, Treckmann J, Paul A, Rahmel A, Squifflet JP, van Heurn E, Monbaliu D, et al. Machine perfusion versus cold storage for the preservation of kidneys donated after cardiac death: a multicenter, randomized, controlled trial. Ann Surg 2010, 252:756-764. 10.1097/SLA.0b013e3181ffc256, 21037431.
9. Garfield SS, Evans RW. Machine perfusion cost-effectiveness versus cold storage has been demonstrated; limiting use to marginal donor kidneys unjustified. Transpl Int 2010, 23:e67-e68. 10.1111/j.1432-2277.2010.01164.x, 20819193.
10. Moers C, Pirenne J, Paul A, Ploeg RJ. Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med 2012, 366:770-771. 10.1056/NEJMc1111038, 22356343.
11. Codas R, Thuillier R, Hauet T, Badet L. Renoprotective effect of pulsatile perfusion machine RM3: pathophysiological and kidney injury biomarker characterization in a preclinical model of autotransplanted pig. BJU Int 2012, 109:141-147. 10.1111/j.1464-410X.2011.10393.x, 21851541.
12. Codas R, Badet L, Eugene M, Giraud S, Thuiller R. Hauet T; group FLIRT: Evaluation of pulsatile perfusion machine RM3 for kidney preservation in a swine model of renal autotransplantation. Transplant Proc 2009 Oct, 41(8):3296-3298.
13. Bradley AJ, Scott MD. Immune complex binding by immunocamouflaged [poly(ethylene glycol)-grafted] erythrocytes. Am J Hematol 2007, 82:970-975. 10.1002/ajh.20956, 17654505.
14. Le Y, Scott MD. Immunocamouflage: the biophysical basis of immunoprotection by grafted methoxypoly(ethylene glycol) (mPEG). Acta Biomater 2010, 6:2631-2641. 10.1016/j.actbio.2010.01.031, 20109585.
15. Giraud S, Favreau F, Chatauret N, Thuillier R, Maiga S, Hauet T. Contribution of large pig for renal ischemia-reperfusion and transplantation studies: the preclinical model. J Biomed Biotechnol 2011, 2011:532127. 3051176, 21403881.
16. Hauet T, Goujon JM, Vandewalle A, Baumert H, Lacoste L, Tillement JP, Eugene M, Carretier M. Trimetazidine reduces renal dysfunction by limiting the cold ischemia/reperfusion injury in autotransplanted pig kidneys. J Am Soc Nephrol 2000, 11:138-148.
17. Grimm PC, Nickerson P, Gough J, McKenna R, Stern E, Jeffery J, Rush DN. Computerized image analysis of Sirius Red-stained renal allograft biopsies as a surrogate marker to predict long-term allograft function. J Am Soc Nephrol 2003, 14:1662-1668. 10.1097/01.ASN.0000066143.02832.5E, 12761269.
18. Chatauret N, Thuillier R, Barrou B, Hauet T, Eugene M. Machine perfusion in clinical trials: the preservation solution bias. Transpl Int 2011, 24:e81-82. 10.1111/j.1432-2277.2011.01300.x, 21749482.
19. Vaziri N, Thuillier R, Favreau FD, Eugene M, Milin S, Chatauret NP, Hauet T, Barrou B. Analysis of machine perfusion benefits in kidney grafts: a preclinical study. J Transl Med 2011, 9:15. 10.1186/1479-5876-9-15, 3038164, 21266040.
20. Codas R, Petruzzo P, Morelon E, Lefrançois N, Danjou F, Berthillot C, Contu P, Espa M, Martin X, Badet L. IGL-1 solution in kidney transplantation: first multi-center study. Clin Transplant 2009, 23(3):337-342. 10.1111/j.1399-0012.2009.00959.x, 19210685.
21. Favreau F, Thuillier R, Cau J, Milin S, Manguy E, Mauco G, Zhu X, Lerman LO, Hauet T. Anti-thrombin therapy during warm ischemia and cold preservation prevents chronic kidney graft fibrosis in a DCD model. Am J Transplant 2009, 10:30-39. 2807130, 19958330.
22. Leong KG, Hu X, Li L, Noseda M, Larrivee B, Hull C, Hood L, Wong F, Karsan A. Activated Notch4 inhibits angiogenesis: role of beta 1-integrin activation. Mol Cell Biol 2002, 22:2830-2841. 10.1128/MCB.22.8.2830-2841.2002, 133705, 11909975.
23. Djamali A. Oxidative stress as a common pathway to chronic tubulointerstitial injury in kidney allografts. Am J Physiol Renal Physiol 2007, 293:F445-455. 10.1152/ajprenal.00037.2007, 17459952.
24. Bedi S, Vidyasagar A, Djamali A. Epithelial-to-mesenchymal transition and chronic allograft tubulointerstitial fibrosis. Transplant Rev (Orlando) 2008, 22:1-5.
25. Burns WC, Kantharidis P, Thomas MC. The role of tubular epithelial-mesenchymal transition in progressive kidney disease. Cells Tissues Organs 2007, 185:222-231. 10.1159/000101323, 17587828.
26. Cheng O, Thuillier R, Sampson E, Schultz G, Ruiz P, Zhang X, Yuen PS, Mannon RB. Connective tissue growth factor is a biomarker and mediator of kidney allograft fibrosis. Am J Transplant 2006, 6:2292-2306. 10.1111/j.1600-6143.2006.01493.x, 16889607.
27. Shirwan H. Chronic allograft rejection. Do the Th2 cells preferentially induced by indirect alloantigen recognition play a dominant role?. Transplantation 1999, 68:715-726. 10.1097/00007890-199909270-00001, 10515369.
28. Dong X, Swaminathan S, Bachman LA, Croatt AJ, Nath KA, Griffin MD. Resident dendritic cells are the predominant TNF-secreting cell in early renal ischemia-reperfusion injury. Kidney Int 2007, 71:619-628. 10.1038/sj.ki.5002132, 17311071.
29. Arslan F, Keogh B, McGuirk P, Parker AE. TLR2 and TLR4 in ischemia reperfusion injury. Mediators Inflamm 2010, 2010:704202. 2902053, 20628516.
30. Campbell MT, Hile KL, Zhang H, Asanuma H, Vanderbrink BA, Rink RR, Meldrum KK. Toll-Like Receptor 4: A Novel Signaling Pathway During Renal Fibrogenesis. J Surg Res 2011, 168:e61-e69. 10.1016/j.jss.2009.09.053, 2888706, 20089260.
31. Thuillier R, Giraud S, Favreau F, Goujon JM, Desurmont T, Eugene M, Barrou B, Hauet T. Improving long-term outcome in allograft transplantation: role of ionic composition and polyethylene glycol. Transplantation 2011, 91:605-614. 10.1097/TP.0b013e3182090fa3, 21317838.
32. Yuan X, Theruvath AJ, Ge X, Floerchinger B, Jurisch A, Garcia-Cardena G, Tullius SG. Machine perfusion or cold storage in organ transplantation: indication, mechanisms, and future perspectives. Transpl Int 2010, 23:561-570. 10.1111/j.1432-2277.2009.01047.x, 20074082.